Hengrui Medicine (01276.HK) plans to globally issue 224.5 million H shares and is expected to be listed on May 23rd.

Intelligence Finance and Economics News App: Hengrui Medicine (01276.HK) is scheduled to go public from May 15th to May 20th, 2025, intending to globally issue 224.5 million H shares, with 5.5% being sold in Hong Kong and 94.5% internationally. The offering price will not exceed HK$44.05 per share and is currently expected to be no less than HK$41.45 per share. Each lot will consist of 200 H shares, and it is anticipated that trading of H shares on the Hong Kong Stock Exchange will begin at 9:00 am on May 23rd, 2025 (Friday).